Brian J Willett, Martin Kraase, Nicola Logan, Elizabeth L McMonagle, Ayman Samman, Margaret J Hosie
BACKGROUND: In the acute phase of infection with feline immunodeficiency virus (FIV), the virus targets activated CD4+ T cells by utilising CD134 (OX40) as a primary attachment receptor and CXCR4 as a co-receptor. The nature of the virus-receptor interaction varies between isolates; strains such as GL8 and CPGammer recognise a "complex" determinant on CD134 formed by cysteine-rich domains (CRDs) 1 and 2 of the molecule while strains such as PPR and B2542 require a more "simple" determinant comprising CRD1 only for infection. These differences in receptor recognition manifest as variations in sensitivity to receptor antagonists. In this study, we ask whether the nature of the virus-receptor interaction evolves in vivo.
RESULTS: Following infection with a homogeneous viral population derived from a pathogenic molecular clone, a quasispecies emerged comprising variants with distinct sensitivities to neutralising antibody and displaying evidence of conversion from a "complex" to a "simple" interaction with CD134. Escape from neutralising antibody was mediated primarily by length and sequence polymorphisms in the V5 region of Env, and these alterations in V5 modulated the virus-receptor interaction as indicated by altered sensitivities to antagonism by both anti-CD134 antibody and soluble CD134.
CONCLUSIONS: The FIV-receptor interaction evolves under the selective pressure of the host humoral immune response, and the V5 loop contributes to the virus-receptor interaction. Our data are consistent with a model whereby viruses with distinct biological properties are present in early versus late infection and with a shift from a "complex" to a "simple" interaction with CD134 with time post-infection.
Nature. 1984 Dec 20-1985 Jan 2;312(5996):763-7
[PMID:
6096719]
Vet Rec. 1989 Sep 9;125(11):293-7
[PMID:
2554556]
Curr HIV Res. 2003 Apr;1(2):217-27
[PMID:
15043204]
J Virol. 2000 Dec;74(24):11858-72
[PMID:
11090186]
J Virol. 2002 Sep;76(18):9242-52
[PMID:
12186908]
J Virol. 1998 Aug;72(8):6858-66
[PMID:
9658135]
J Virol. 1999 Dec;73(12):10489-502
[PMID:
10559367]
Retrovirology. 2008 Aug 22;5:77
[PMID:
18721458]
Immunol Today. 1997 Apr;18(4):182-9
[PMID:
9136455]
Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8392-6
[PMID:
7690960]
J Gen Virol. 2006 Mar;87(Pt 3):581-594
[PMID:
16476979]
J Virol. 2006 Aug;80(15):7744-7
[PMID:
16840353]
J Virol. 2002 Jun;76(12):6062-72
[PMID:
12021339]
In Vitro Cell Dev Biol. 1990 May;26(5):455-63
[PMID:
2161827]
J Virol. 1999 Feb;73(2):1655-60
[PMID:
9882375]
Science. 1996 Jun 28;272(5270):1955-8
[PMID:
8658171]
Virology. 2007 Mar 1;359(1):92-104
[PMID:
17052738]
J Virol. 1990 Nov;64(11):5652-5
[PMID:
1976826]
J Virol. 1995 May;69(5):3167-70
[PMID:
7707545]
Mol Cell Biol. 1987 Jan;7(1):379-87
[PMID:
3031469]
J Virol. 2007 Sep;81(18):9665-79
[PMID:
17609274]
J Gen Virol. 2010 Jan;91(Pt 1):242-9
[PMID:
19776242]
J Virol. 1997 Sep;71(9):6407-15
[PMID:
9261358]
Trends Microbiol. 1995 Sep;3(9):356-61
[PMID:
8520889]
Proc Natl Acad Sci U S A. 2004 Aug 31;101(35):13044-9
[PMID:
15326292]
J Virol. 2001 Sep;75(18):8868-73
[PMID:
11507234]
J Virol. 2008 Jul;82(14):7089-99
[PMID:
18480460]
Virology. 1995 Feb 1;206(2):935-44
[PMID:
7531918]
Vet Immunol Immunopathol. 1992 Dec;35(1-2):3-13
[PMID:
1337400]
Virology. 1993 Feb;192(2):659-62
[PMID:
8380668]
Arch Virol. 1989;108(1-2):131-5
[PMID:
2480760]
J Virol. 2001 May;75(10):4584-93
[PMID:
11312328]
J Virol. 1993 Sep;67(9):5175-86
[PMID:
7688819]
J Virol. 1996 Aug;70(8):5165-9
[PMID:
8764024]
J Virol. 2000 Oct;74(20):9403-11
[PMID:
11000209]
Nature. 1997 Feb 13;385(6617):587
[PMID:
9024654]
Annu Rev Immunol. 1999;17:657-700
[PMID:
10358771]
J Virol. 2004 Oct;78(20):11296-302
[PMID:
15452249]
J Am Vet Med Assoc. 1989 Jan 15;194(2):213-20
[PMID:
2537269]
J Virol. 1991 May;65(5):2225-30
[PMID:
1673159]
J Virol. 1999 May;73(5):3661-71
[PMID:
10196258]
Mol Immunol. 2009 Mar;46(6):1020-30
[PMID:
19181384]
J Virol. 2004 Mar;78(6):2722-8
[PMID:
14990692]
J Virol. 1995 Aug;69(8):5124-7
[PMID:
7609081]
Vet Immunol Immunopathol. 2008 May 15;123(1-2):56-64
[PMID:
18289703]
Nat Struct Mol Biol. 2005 Jan;12(1):60-6
[PMID:
15592478]
Vet Pathol. 1996 May;33(3):264-72
[PMID:
8740699]
Vet Immunol Immunopathol. 2010 Mar 15;134(1-2):96-106
[PMID:
19897254]
Vet Rec. 2010 Feb 6;166(6):163-8
[PMID:
20139379]
J Exp Med. 1997 Feb 17;185(4):621-8
[PMID:
9034141]
Science. 1996 May 10;272(5263):872-7
[PMID:
8629022]
J Virol. 2006 Mar;80(6):3088-91
[PMID:
16501119]
J Virol. 1997 Oct;71(10):7478-87
[PMID:
9311827]
AIDS. 1989;3 Suppl 1:S43-9
[PMID:
2558688]
Nat Med. 1997 Nov;3(11):1259-65
[PMID:
9359702]
Nature. 1996 Jun 20;381(6584):661-6
[PMID:
8649511]
J Virol. 2006 Apr;80(7):3386-94
[PMID:
16537606]
Nature. 1996 Jun 20;381(6584):667-73
[PMID:
8649512]
Clin Microbiol Rev. 1995 Jan;8(1):87-112
[PMID:
7704896]
Nature. 1984 Dec 20-1985 Jan 2;312(5996):767-8
[PMID:
6083454]
Science. 1987 Feb 13;235(4790):790-3
[PMID:
3643650]
J Virol. 2004 Jan;78(1):524-30
[PMID:
14671134]
Science. 2004 Feb 20;303(5661):1192-5
[PMID:
14976315]
Cell. 1986 Nov 7;47(3):333-48
[PMID:
3094962]
